1. Salmon calcitonin (miacalcic ns 200 iu) in prevention of bone loss after hip replacement;Arnala;Scand J Surg,2012
2. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the oral calcitonin in postmenopausal osteoporosis (ORACAL) trial;Binkley;J Bone Miner Res,2012
3. Antiresorptive therapies for osteoporosis: a clinical overview;Chen;Nature Reviews Endocrinology,2012
4. Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis;Knopp-Sihota;Osteoporos Int,2012
5. FDA. Joint meeting of the advisory committee for reproductive health drugs and drug safety and risk management advisory committee (Meeting minutes). Retrieved from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM351017.pdf.March. 5th 2013.